Health Care/Hospital APAC News & Press Release Distribution

Lynk Pharmaceuticals and Simcere announced Strategic Commercialization Partnership upon novel JAK1 inhibitor LNK01001

HANGZHOU, China, March 18, 2022 /PRNewswire/ -- On March 18, 2022, Lynk Pharmaceuticals Co., Ltd. (Lynk Pharmaceuticals) and Simcere (2096.HK) announced a strategic partnership to develop and commercialize a highly selective JAK1 inhibitor LNK01001 inChina. Under the terms of the agreement, Lynk...

2022-03-18 13:28 3998

CStone Pharmaceuticals Announces the Acceptance of New Drug Application (NDA) for Pralsetinib for the Treatment of RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC) in Hong Kong, China

SUZHOU, China, March 18, 2022 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, announced today that the new drug application (...

2022-03-18 10:35 2603

ZEPP HEALTH RANKED TOP FIVE IN GLOBAL SMARTWATCH SHIPMENTS IN 2021

Global sales continued to excel in Brazil, Turkey, Italy, and the Czech Republic in Q4 2021 CUPERTINO, Calif., March 18, 2022 /PRNewswire/ -- Zepp Health (NYSE: ZEPP), a global smart wearable and health technology leader, completed the final quarter of 2021 with yet another season of sharp and s...

2022-03-18 10:09 2802

ZEPP HEALTH RANKED TOP FIVE IN GLOBAL SMARTWATCH SHIPMENTS IN 2021

CStone announced the global multi-regional registration trial of anti-PD-1 antibody nofazinlimab in combination with lenvatinib as first-line treatment for patients with advanced hepatocellular carcinoma successfully reached the prespecified enrollment target

SUZHOU, China, March 18, 2022 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the global multi-regional ...

2022-03-18 08:37 2933

Led by OrbiMed, HiRO Raised Tens of Millions of US Dollars in Series A Financing, to Offer Multinational Global Clinical Development Strategy

SHANGHAI, March 18, 2022 /PRNewswire/ -- Harvest Integrated Research Organization ("HiRO" or the "Company") announced the completion of its Series A financing in the tens of millions of US dollars. This round of investment is led by OrbiMed, with the participation from existing shareholder, Fontu...

2022-03-18 08:00 2779

Manipal Hospitals partners with ConnectedLife, leveraging Fitbit wearable technology, for Continuity of Care Post-High-Risk Surgeries built with Google Cloud

First of its kind initiative in India bringing wearable technology for post-surgery care. NEW DELHI and LONDON and SINGAPORE, March 18, 2022 /PRNewswire/ -- Manipal Hospitals, the second-largest healthcare services provider inIndia, today announced a strategic partnership with ConnectedLife buil...

2022-03-18 06:00 2259

Ping An Reports Steady YoY Growth of 6.1% in Operating Profit Attributable to Shareholders of the Parent Company in 2021

Attaching great importance to shareholder returns, annual cash dividend per share grew by 8.2% year on year HONG KONG and SHANGHAI, March 17, 2022 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An of China," "Ping An," the "Company" or the "Group," HKEX: 2318; ...

2022-03-17 22:54 3447

BioVaxys Announces Bioproduction of BVX-1021 for its Pan-Sarbecovirus Program in Collaboration with The Ohio State University

VANCOUVER, BC, March 17, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that it has entered into an agreement with Millipore-Sigma ("Millipore") a global Contract Development and Manufacturing Research Organization (...

2022-03-17 20:18 2851

EVERSANA unveils global price and market access solution NAVLIN by EVERSANA

Next generation price and market access platform combining data, software and insights into single ecosystem CHICAGO, March 17, 2022 /PRNewswire/ -- EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today unveiledNAVLIN by EVERSANA™, a new, compr...

2022-03-17 19:10 1454

Digital Transformation Takes Center Stage at Frost & Sullivan's MEASA Best Practices Awards

18 awards were presented to companies demonstrating excellence in leadership and innovation at the virtual awards ceremony MUMBAI, India, March 17, 2022 /PRNewswire/ -- At the 9th edition of Frost & Sullivan's Best Practices Awards for the Middle East, Africa, and South Asia (MEASA) region onMar...

2022-03-17 17:45 7387

Digital Transformation Takes Center Stage at Frost & Sullivan's MEASA Best Practices Awards

First eye drops registered on the Australian Register of Therapeutic Goods (ARTG) to slow the progression of short-sightedness now available for children aged from 4 to 14 years old[1]

SYDNEY, March 17, 2022 /PRNewswire/ -- Aspen announced the Therapeutic Goods Administration (TGA) listing of a new medication to slow the progression of short-sightedness (myopia) in children and young teenagers. EIKANCE® 0.01% eye drops (atropine sulfate monohydrate 0.01%) are available on presc...

2022-03-17 17:00 2475

KeyZell start-up plans to reach 5 million euros in private investment and become the new biotech unicorn

MADRID, March 17, 2022 /PRNewswire/ -- KeyZell, a Spanish biotechnology company in the development phase of digital cancer treatments and tools, has just opened a private financing round which expects to achieve5 million euros to boost its projects and consolidate itself as one of the biotech sta...

2022-03-17 15:30 2456

MGI Helps Combat COVID-19 Pandemic in Laos with Innovative Container Laboratory Thanks to the Support of LSEA

PAKSE, Laos, March 17, 2022 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a global life science leader and innovator, has developed Champa LSEA Laboratory, the first 3rd party detection center in Laos, under the support of the Belt and Road Life Science Economy Alliance (LSEA) and Sithandone Joint De...

2022-03-17 14:00 2265

Hydro-Nanogel, an Innovative Bath-substituting Product for Clean, Cuddly, and Healthy Pets

BANGKOK, March 17, 2022 /PRNewswire/ -- Chula Veterinary Science (CUVET) releases its cutting-edge innovation, "Hydro-Nanogel", a bath-substituting cleansing product for pets. The Hydro-Nanogel is great for pet care when they are not allowed to bathe, or hate taking a bath, it is poised to be fur...

2022-03-17 10:00 1775

Hydro-Nanogel, an Innovative Bath-substituting Product for Clean, Cuddly, and Healthy Pets

Henlius 2021 Annual Results: New Record in Performance, Evolving to Biopharma

SHANGHAI, March 17, 2022 /PRNewswire/ -- Henlius (2696.HK) announced its annual results for the year endedDecember 31st, 2021, sharing the company's recent noteworthy progress and achievements. As a global innovative biopharmaceutical company, Henlius is committed to offering high-quality, afford...

2022-03-17 08:00 2976

Henlius 2021 Annual Results: New Record in Performance, Evolving to Biopharma

SHANGHAI, March 16, 2022 /PRNewswire/ -- Henlius (2696.HK) announced its annual results for the year endedDecember 31st, 2021, sharing the company's recent noteworthy progress and achievements. As a global innovative biopharmaceutical company, Henlius is committed to offering high-quality, afford...

2022-03-16 23:46 1810

Breakthrough Study Validates Artificial Intelligence as a Novel Biomarker in Predicting Immunotherapy Response - Published in Journal of Clinical Oncology

* Lunit's latest study provides evidence for Lunit SCOPE IO's ability to predict immunotherapy response * This is the first study that adopted AI technology to define the tumor immune phenotype and to demonstrate its ability in predicting treatment outcomes of anti-PD-L1 therapy SEOUL, South ...

2022-03-16 21:09 1825

Breakthrough Study Validates Artificial Intelligence as a Novel Biomarker in Predicting Immunotherapy Response - Published in Journal of Clinical Oncology

Terran Biosciences announces licensing deal with Columbia University for exclusive worldwide rights to proprietary CNS biomarker software platform

NEW YORK, March 16, 2022 /PRNewswire/ -- Terran Biosciences, Inc. ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics and technologies for neurological and psychiatric diseases, has entered into an agreement withColumbia University ("Columbia") and...

2022-03-16 20:38 2346

Innoforce and Hibiscus BioVentures Announce Strategic Partnership to Enable Development of Advanced Therapies

- Partnership enables Hibiscus BioTechnology Studio Companies access to Innoforce's advanced therapies drug development capabilities - HANGZHOU, China and ROCKVILLE, Md., March 16, 2022 /PRNewswire/ -- Innoforce, a global development and biomanufacturing company focused on Advanced Therapy Medic...

2022-03-16 19:00 1623

Adagene Announces FDA Clearance to Proceed with Phase 1b/2 Trial of Anti-CTLA-4 ADG126 SAFEbody® in Combination Therapy With Anti-PD-1 Antibody Pembrolizumab

SAN DIEGO and SUZHOU, China, March 16, 2022 /PRNewswire/ -- Adagene Inc. ("Adagene") (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced FDA clearance to proceed with a Phase1b/2 clinical trial of its anti-CTLA-4 monoclonal antib...

2022-03-16 19:00 2315